Impact
Report

At the end of each financial year, it is an opportune moment for us to present our impact, particularly in how funds are raised and allocated to cancer research.

Once again, the 2022-2023 Impact Report demonstrates that the Cancer Research Society (CRS) has reaffirmed its role as a pivotal leader in funding cancer research in Canada. Despite a year marked by inflation, the CRS stayed the course and funded the highest number of research projects in its history for the second consecutive year.

Thus, a total of $13.3 million was invested in 225 promising projects to advance research across all types of cancer.